000 01211 a2200325 4500
005 20250518091615.0
264 0 _c20201209
008 202012s 0 0 eng d
022 _a1558-3597
024 7 _a10.1016/j.jacc.2019.12.057
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCoylewright, Megan
245 0 0 _aTAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making.
_h[electronic resource]
260 _bJournal of the American College of Cardiology
_c03 2020
300 _a1208-1211 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAortic Valve Stenosis
_xepidemiology
650 0 4 _aClinical Decision-Making
_xmethods
650 0 4 _aDecision Making, Shared
650 0 4 _aDevice Approval
650 0 4 _aHumans
650 0 4 _aInsurance Coverage
_xtrends
650 0 4 _aRisk Factors
650 0 4 _aTranscatheter Aortic Valve Replacement
_xmethods
700 1 _aForrest, John K
700 1 _aMcCabe, James M
700 1 _aNazif, Tamim M
773 0 _tJournal of the American College of Cardiology
_gvol. 75
_gno. 10
_gp. 1208-1211
856 4 0 _uhttps://doi.org/10.1016/j.jacc.2019.12.057
_zAvailable from publisher's website
999 _c30735238
_d30735238